Metastatic Renal Cell Carcinoma ( mRCC)Phase 2NCT06601296
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
IMSA101
43 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Kidney and bladder43 studies
Metastatic Renal Cell Carcinoma ( mRCC)Phase 2NCT06601296
IMSA101
Hereditary Leiomyomatosis and Renal Cell CarcinomaPhase 2NCT04981509
Atezolizumab, Bevacizumab, Biopsy Procedure, Biospecimen Collection
Bladder AdenocarcinomaPhase 2NCT03866382Papers
Biospecimen Collection, Bone Scan, Cabozantinib S-malate, Computed Tomography
Low-grade NMIBCPhase 2NCT06995677
TYRA-300 60mg, TYRA-300 50mg, TYRA-300 Dose 70 mg
Localized Clear Cell Renal Cell CarcinomaPhase 2NCT07226544
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test
RCCPhase 2NCT05931393
Cabozantinib 80 MG
Metastatic Renal Cell CarcinomaPhase 2NCT05327686
Avelumab, Axitinib, Biospecimen Collection, Bone Scan
Muscle-invasive Bladder CancerPhase 2NCT07475806
Enfortumab Vedotin, Pembrolizumab
Clear Cell Renal Cell CarcinomaPhase 2NCT07516366
Balstilimab, Biospecimen Collection, Botensilimab, Computed Tomography
Clear Cell Renal Cell CarcinomaPhase 2NCT07037004
Biospecimen Collection, Clostridium butyricum CBM588 Strain, Computed Tomography, Pembrolizumab
Non-Muscle Invasive Bladder Urothelial CarcinomaPhase 2NCT06770582
Biospecimen Collection, Cisplatin, Computed Tomography, Fluorouracil
Small Cell Carcinoma of the BladderPhase 2NCT06228066Papers
Lurbinectedin, Avelumab
Small Cell Carcinoma of the BladderPhase 2NCT06161532Papers
Sacituzumab govitecan, Atezolizumab
Advanced or Metastatic Clear Cell Renal Cell CarcinomaPhase 1NCT07564232
LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma
Locally Advanced Urothelial CarcinomaPhase 2NCT07048457
Radical cystectomy
Renal Cell CarcinomaPhase 2NCT06053658
Tivozanib, Nivolumab
Non-muscle Invasive Bladder CancerPhase 2NCT06503614
Durvalumab, Monalizumab
Bladder Urothelial CarcinomaPhase 2NCT06263153
Biospecimen Collection, Computed Tomography, Durvalumab, Futibatinib
Phase IIPhase 2NCT07438626
Sacituzumab tirumotecan
Renal Cell CarcinomaPhase 2NCT05319015
Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection, Adjuvant Pembrolizumab
Urothelial Carcinoma BladderPhase 2NCT06184516
Reproductive organ sparing radical cystectomy, Radical cystectomy
Advanced Renal Cell Carcinoma (aRCC)Phase 2NCT07188896
Fianlimab, Ipilimumab, Nivolumab, Cemiplimab
Locally Advanced Renal Cell CarcinomaPhase 2NCT06794229
Zanzalintinib, Nivolumab
High-Risk Non-Muscle-Invasive Bladder CancerPhase 2NCT06567743
Cretostimogene Grenadenorepvec